title: Intracytoplasmic morphologically selected sperm injection benefits for patients with oligoasthenozoospermia according to the 2010 World Health Organization reference values.
abstract: The comparison between the outcomes of intracytoplasmic morphologically selected sperm injection performed in couples with male factor infertility according to the World Health Organization guidelines from 1999 and 2010 was the objective of this study. Our results suggest that the sperm selection under high magnification results in improved treatment outcomes in patients with oligoasthenoteratozoospermia, according to the new World Health Organization guidelines.
authors: Sapientiae Institute-Educational and Research Center in Assisted Reproduction, São Paulo, Brazil.
authors: Amanda S
authors: AS
authors: Setti
authors: Rita de Cássia S
authors: Rde C
authors: Figueira
authors: Daniela P A F
authors: DP
authors: Braga
authors: Assumpto
authors: A
authors: Iaconelli
authors: Edson
authors: E
authors: Borges
mesh_terms: D000022:Abortion, Spontaneous / Q000209:etiology; D000328:Adult; D001938:Brazil; D010064:Embryo Implantation; D005260:Female; D006801:Humans; D007248:Infertility, Male / Q000473:pathology / Q000628:therapy*; D008297:Male; D016017:Odds Ratio; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D018873:Pregnancy Rate; D011446:Prospective Studies; D012016:Reference Values; D055101:Semen Analysis / Q000592:standards*; D020554:Sperm Injections, Intracytoplasmic / Q000009:adverse effects / Q000592:standards*; D013094:Spermatozoa / Q000648:ultrastructure*; D013997:Time Factors; D016896:Treatment Outcome; D014944:World Health Organization